Orchestra BioMed Holdings (OBIO) Operating Leases (2022 - 2026)

Orchestra BioMed Holdings (OBIO) has 5 years of Operating Leases data on file, last reported at $730000.0 in Q1 2026.

• On a quarterly basis, Operating Leases fell 51.85% year-over-year to $730000.0 in Q1 2026; TTM through Mar 2026 was $730000.0, a 51.85% decrease from a year earlier, with the FY2025 full-year figure at $936000.0, down 44.52% from the prior year.
• Operating Leases for Q1 2026 stood at $730000.0, down from $936000.0 in the prior quarter.
• Over the last five years, Operating Leases for OBIO reached as high as $1.7 million in Q4 2024 and fell as low as $730000.0 in Q1 2026.
• Historically, Operating Leases has averaged $1.3 million across 5 years, with a median of $1.2 million in 2023.
• Across the five-year window, Operating Leases soared 62.52% in 2024 and tumbled 51.85% in 2026, its largest moves.
• Year by year, Operating Leases stood at $1.7 million in 2022, then tumbled by 38.32% to $1.0 million in 2023, then surged by 62.52% to $1.7 million in 2024, then plunged by 44.52% to $936000.0 in 2025, then dropped by 22.01% to $730000.0 in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $730000.0 in Q1 2026, $936000.0 in Q4 2025, and $1.1 million in Q3 2025.